Coronavirus, Covid-19, Vaccines, Pharmaceuticals Sector

Coronavirus, Covid-19

AstraZeneca says likely to run new global trial on Covid-19 vaccine

AstraZeneca says likely to run new global trial on Covid-19 vaccine

26/11/2020 8:03:00 PM

AstraZeneca says likely to run new global trial on Covid-19 vaccine

LONDON (REUTERS) - AstraZeneca is likely to run an additional global trial to assess the efficacy of its Covid-19 vaccine, according to the company's Chief Executive Pascal Soriot, Bloomberg News reported on Thursday (Nov 26).. Read more at straitstimes.com.

Instead of adding the trial arm to an ongoing US process, a new trial would be run to evaluate a lower dosage that performed better than a full amount in AstraZeneca's studies, the report said.AstraZeneca is facing tricky questions about its success rate that some experts say could hinder its chances of getting speedy US and EU regulatory approval.

COVID-19 pandemic could last 4 to 5 years: Lawrence Wong China says US military in South China Sea not good for peace China says coronavirus traces found in vaccination sites, but not infectious Read more: The Straits Times »

Is the vaccine really safe?